Media & Technology
Swift Rise of Amazonas Florestal Ltd (AZFL) Pink Current, Green America Labs (GAL) Florida Hemp Oil Extraction Facility & Move on Mexican Cannabis Markets
Amazonas Florestal Ltd (AZFL) is making a highly explosive move up the charts in recent months out of the triple zeroes to recent highs near a penny with double digit pennyland now well within sites. The stock has quickly attracted legions of new shareholders and transformed into a volume leader in small caps regularly trading over $10 million USD per day in dollar volume. We recently reported on AZFL and noted that these are different, unique and exciting times for penny stocks as they have reached the mainstream like they never have before. Now it’s common for penny stocks to run from triple zeroes to $0.50 or higher and we have reported on many of them including ALPP, TSNP, ENZC, OZSC just to name a few.
AZFL was up over 60% on Tuesday alone on $9.5 million in dollar volume and over a billion shares traded as the Company began the process of uploading all filings to OtcMarkets Group and should return the Company to “pink current” status as a Pink Sheets Information Tier company within the next 2 days. AZFL is getting noticed by investors as the Company’s new management team, highly connected in Mexico Make a play on the soon to be legalzied and enormous fast growing Medican Cannabis Market. AZFL is also building out its Hemp Oil Extraction facility in South Florida. The new facility will be one of the first of its kind this far south with standardized operating procedures to produce bulk T-Free concentrates for the Florida and Latin American Markets with an expected launch date of Mayb 15, 2021. AZFL BOD has appointed Carlos Martinez as its new CFO, and Mr. Jose Giron as General Manager to direct the Green America Laboratories project. GAL brings together an important group of investors led by Mr. Raul Rocha Cantu, a Mexican businessman whose home group owns and operates the largest private gaming establishments in Mexico. GAL, as it has now been baptized, will be directed by AZFL’s Company Chairman, Ricardo Cortez, in conjunction with Mr. Rocha Cantu and Mr. Alejandro Otero, also a Mexican businessman and land-owner who has also contributed with important guarantees to the GAL Project.
AZFL (Amazonas Florestal Ltd.) operating out of South, Florida mission is to become a leader in field of Cannabinoid Extractions serving labs that use these chemicals as a raw material for human and animal health and beauty products. The Company is currently building out its Hemp Oil Extraction facility in South Florida dedicated to the production of premium bulk cannabinoid extractions derived from Hemp and products that use these extractions as an active ingredient for Health and Wellness products. Like most otc AZFL has a checkered past and once can read about it here. AZFL has created a new wholly owned subsidiary; Green America Labs “GAL” to house the Company’s new Hemp Oil Extraction facility in South Florida. GAL is focused on becoming the first major processor of Hemp Biomass in South Florida. GAL plans to operate the most advanced extraction equipment made today in a sterile lab environment to process premium concentrations of THC Free Cannabinoids and Terpenes that are sold in bulk quantities to labs and brand confectioners that do not have extraction capability and require concentrates of legal cannabinoids in their formulas. Green America GAL will bring Concentrated Bulk Extracts and Highest Quality Premium THC-Free High CBD Hemp Bulk Concentrates, Crude Oil, T-Free Distillates and 99.9% and Pure Crystalized Isolates to the Florida and Latin American Markets. Initial products will include High CBD Concentrated Crude Oil Extract (60%-65%), GAL Premier T-Free High CBD Distillate (80%-85%) and T-Free Purified/Sterile Isolate (99.9% CBD Powder)
The management team at Green America Laboratories—along with the design contributions proposed by Grim Leadingham, GALs executive technical consultant—approved the final design concept for its Miami, FL facility.
Have a look inside! pic.twitter.com/IZ8GSeUBXG
— AZFL (@AZFLUS) March 16, 2021
The new Hemp Oil extraction lab in South Florida is one of the first of its kind this far south with standardized operating procedures to produce bulk T-Free concentrates for the Florida and Latin American Markets with an expected launch date of Mayb 15, 2021 as Microcapdaily previously reported. Green America Laboratories has already secured a facility in NW Miami-Dade County where the company will be building a top-of-the-line Hemp derived products lab. GAL has selected and ordered a new lab configuration with equipment manufactured by Precision Extraction Solutions of Troy, Michigan. Precision, widely considered the best USA manufacturer of solvent based cannabinoid extraction equipment, was founded by Mr. Nick Tennant, world renowned as the USA’s Extraction Guru. GAL has hired architects and engineers to design the lab layout under the technical direction of Mr. Grim Leadingham of WKU Consulting. Mr. Leadingham and his team are accredited with 100% effectiveness in the business, having helped built some of the largest bulk concentrates laboratories on the west coast and with a perfect 9 for 9 record in labs built and labs operating successfully. GAL’s standardized operating procedures aim to produce bulk T-Free concentrates and premium T-Free distillates for the emerging Florida and Latin American Markets.
https://twitter.com/DrewDiligencee/status/1374398118628716545
To Find out the inside Scoop on AZFL Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
The updated q3 filing shows a healthy balance sheet with manageable debt and significant land holdings including 64,000 acres of rain forest in Brazil, another 150 acres or so in Santa Cruz, Brazil and 100 acres in Frederick, Colorado where they previously planted Hemp; unfortunately, the thc content was too high and they had to abandon the harvest. On their books they list their land holdings as: Central Borba – $598,919, Earth Pass $2,702,715, 303 Farms LLC $666,115, Colorado Farms 1,073,980. They also list a $120,000 investment in a Peru Lumber Farm.
AZFL BOD has appointed Carlos Martinez as its new CFO, and Mr. Jose Giron as General Manager to direct the Green America Laboratories project. GAL brings together an important group of investors led by Mr. Raul Rocha Cantu, a Mexican businessman whose home group owns and operates the largest private gaming establishments in Mexico. GAL, as it has now been baptized, will be directed by AZFL’s Company Chairman, Ricardo Cortez, in conjunction with Mr. Rocha Cantu and Mr. Alejandro Otero, also a Mexican businessman and land-owner who has also contributed with important guarantees to the GAL Project.
Management has been active on twitter recently reporting CEO Ricardo Cortez had a productive meeting at COFEPRIS (Federal Committee for Protection Against Sanitary Risk) headquarters in Mexico City, Mexico. AZFL is working closely with local attorneys and medical professionals to bring its products to the Mexican markets.
Our CEO, Ricardo Cortez had a productive meeting at COFEPRIS (Federal Committee for Protection Against Sanitary Risk) headquarters in Mexico City, Mexico.
AZFL is working closely with local attorneys and medical professionals to bring our products to the Mexican markets. 🇲🇽 pic.twitter.com/tonnlof2DO
— AZFL (@AZFLUS) March 18, 2021
On March 4 AZFL chairman, Ricardo Cortez, joined fellow shareholders and Green America Laboratories Directors, Raul Rocha and Alex Otero, to visit ISOLERA Extractions at their lab facility located near Oxford, North Carolina. The GAL Directors intend to negotiate a potential joint venture with ISOLERA to formulate and manufacture products for the new and rapidly growing Mexican markets. ISOLERA is one of the largest Hemp processors in the USA and manufactures premium grade distillates and high CBD Edible products. GAL is set to become one the largest Hemp processors in the State of Florida with operations due to inaugurate in late May 2021. Both companies agreed to further explore their mutual intentions to come together as a group to manufacture products for the Mexican medical marijuana markets initially and agreed the real potential will come later this year when Mexico completes legislation to allow the licensed distribution of adult use recreational marijuana products. The new group signaled intentions to work together in the development of products for these new emerging markets.
1/5 $AZFL company chairman , Ricardo Cortez, joined fellow shareholders and Green America Laboratories Directors, Raul Rocha and Alex Otero, to visit ISOLERA Extractions at their lab facility located near Oxford, North Carolina. The GAL Directors intend to negotiate a potential pic.twitter.com/lxMPSjpmFf
— AZFL (@AZFLUS) March 4, 2021
For More on AZFL Subscribe Right Now!
Amazonas Florestal Ltd (AZFL) is making a highly explosive move up the charts in recent months out of the triple zeroes to recent highs near a penny with double digit pennyland now well within sites. The stock has quickly attracted legions of new shareholders and transformed into a volume leader in small caps regularly trading over $10 million USD per day in dollar volume. We recently reported on AZFL and noted that these are different, unique and exciting times for penny stocks as they have reached the mainstream like they never have before. Now it’s common for penny stocks to run from triple zeroes to $0.50 or higher and we have reported on many of them including ALPP, TSNP, ENZC, OZSC just to name a few. AZFL was up over 60% on Tuesday alone on $9.5 million in dollar volume and over a billion shares traded as the Company began the process of uploading all filings to OtcMarkets Group and should return the Company to “pink current” status as a Pink Sheets Information Tier company within the next 2 days. The updated annual report shows a healthy balance sheet with manageable debt and significant land holdings including 64,000 acres of rain forest in Brazil, another 150 acres or so in Santa Cruz, Brazil and 100 acres in Frederick, Colorado where they previously planted Hemp; unfortunately, the thc content was too high and they had to abandon the harvest. On their books they list their land holdings as: Central Borba – $598,919, Earth Pass $2,702,715, 303 Farms LLC $666,115, Colorado Farms 1,073,980. They also list a $120,000 investment in a Peru Lumber Farm. AZFL has created a new wholly owned subsidiary; Green America Labs “GAL” to house the Company’s new Hemp Oil Extraction facility in South Florida. The new facility will be one of the first of its kind this far south with standardized operating procedures to produce bulk T-Free concentrates for the Florida and Latin American Markets with an expected launch date of Mayb 15, 2021. Management has been active on twitter recently reporting CEO Ricardo Cortez had a productive meeting at COFEPRIS (Federal Committee for Protection Against Sanitary Risk) headquarters in Mexico City, Mexico. AZFL is working closely with local attorneys and medical professionals to bring its products to the Mexican markets. On March 4 AZFL chairman, Ricardo Cortez, joined fellow shareholders and Green America Laboratories Directors, Raul Rocha and Alex Otero, to visit ISOLERA Extractions at their lab facility located near Oxford, North Carolina. The GAL Directors intend to negotiate a potential joint venture with ISOLERA to formulate and manufacture products for the new and rapidly growing Mexican markets. We will be updating on AZFL when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with AZFL.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in AZFL either long or short and we have not been compensated for this article.
LAVA Therapeutics N.V. (NASDAQ: LVTX) shares soared 106% as the company announced that Janssen Biotech, Inc., a part of the Janssen Pharmaceutical Companies of Johnson & Johnson, chose a lead candidate aimed at an undisclosed tumor-associated antigen for further development towards clinical settings.
GAMMABODY™ PLATFORM
LAVA primarily focuses on revolutionizing cancer therapy by developing its Gammabody™ platform. This platform enables them to create bispecific gamma delta T cell engagers that can activate a specific subset of gamma-delta T cells called Vγ9Vδ2 (Vgamma9 Vdelta2) T cells. By utilizing this approach, they aim to enhance the natural recognition of tumors, guide Vγ9Vδ2 T cells to target the tumor cells directly and trigger a cascade of immune responses.
To Discover the Inside Scoop on LVTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
What sets their Gammabody™ drug candidates apart is their exceptional performance and safety profiles observed in preclinical studies. Compared to other bispecific T cell engager approaches, their candidates have demonstrated superior efficacy and preferred targeting tumor cells. This targeted approach has the potential to minimize toxicity in healthy tissues.
In May 2020, LAVA entered into a research collaboration and license agreement with Janssen, a subsidiary of the Janssen Pharmaceutical Companies of Johnson & Johnson. This collaboration aimed to discover and develop novel bispecific antibody-based gamma delta T cell engagers for cancer treatment. The agreement was facilitated by Johnson & Johnson Innovation, emphasizing their commitment to fostering innovation in the field.
My big % winning day trade today was $LVTX.
All I did was follow the system.
It has a small float.
Fresh meet never pumped before.
Big News out.
Giant volume.
Why I jumped in early and took profits on the spike in volume. pic.twitter.com/2knPeC5RHz— Trader Brian Jones (@MasterBJones) June 2, 2023
As part of the collaboration, LAVA had the opportunity to receive potential milestone payments and royalties based on the successful development, regulatory approvals, and commercialization of the candidates. This incentivized LAVA to actively pursue the discovery and advancement of promising lead candidates.
The collaboration represents a remarkable milestone many early-stage biotech companies aspire to achieve. Partnering with a program brings numerous benefits, including reduced risk of dilution through milestone payments as the trials advance and streamlined commercialization once the product receives approval.
$LVTX $66mil mcap, $133mil in cash at the end of December, cash runway into 2026, median price target $13 (443% upside)
— Jake Weber (@BioStockAnalyst) June 2, 2023
Under the terms of the agreement, Janssen will assume responsibility for the selected candidate’s future clinical development, manufacturing, and commercialization. This includes bearing the costs and expenses associated with these activities.
Stephen Hurly, LAVA Therapeutics’s president and chief executive officer, expressed satisfaction with Janssen’s selection of a lead candidate for clinical studies. He emphasized LAVA’s pioneering role in developing gamma-delta bispecific antibodies through their proprietary Gammabody platform. This platform and LAVA’s extensive expertise in bispecific antibody development position them at the forefront of advancing novel therapies for cancer patients.
$LVTX has three gamma-delta t cell drug candidates in early-stage trials, including collaboration with $SGEN for solid tumors.
— Jake Weber (@BioStockAnalyst) June 2, 2023
In summary, LAVA Therapeutics’ collaboration with Janssen has reached a significant milestone in selecting a lead candidate for further development toward clinical studies. This progress underscores LAVA’s dedication to leveraging its Gammabody platform and expertise in bispecific antibody development to revolutionize cancer treatment.
We will update you on LVTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
Onfolio Holdings Inc (NASDAQ: ONFO), a technology services company, has recently introduced an advanced generative AI search function for its subsidiary, MightyDeals.com. The implementation of this innovative AI tool, powered by chatGPT-style Large Language Models (LLMs), has resulted in a surge of 105% in the company’s stock price and sparked tons of investor interest. The company has a 3.28M float and, at the time of writing, has traded 20x that amount, with a colossal 60M shares exchanging hands.
Revolutionizing User Experience and Driving Stock Surge
$onfo in news and float are lit pic.twitter.com/7afKMOfdz2
— …frankyboyz… (@frankyboyz77) May 26, 2023
With the integration of AI search on MightyDeals.com, customers can now use natural language to describe the products they seek, simplifying the buying process. The AI tool utilizes contextual understanding and description analysis of hundreds of active deals to generate instant search results based on users’ queries. By enhancing the user experience, Onfolio Holdings anticipates increased user return rates, higher site interaction rates, and elevated revenues for MightyDeals.com. This groundbreaking development has attracted positive attention, significantly increasing Onfolio Holdings’ stock price.
To Discover the Inside Scoop on ONFO, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
$ONFO just took the elevator to the top!
Now just waiting on $CYTO pic.twitter.com/OfJgNb1ty0
— 💎 DBR 💎 (@dbr_land) May 26, 2023
Evaluating Financial Performance
While the stock surge indicates investor enthusiasm, assessing Onfolio Holdings’ financial performance is crucial for comprehensive investment analysis. The positive earnings growth of +44.44% and revenue growth of +22.74% contribute to the company’s optimistic outlook. However, investors should be cautious of the negative net profit margin of -190.75% and the lack of available price/book ratio data. Monitoring the company’s financial performance leading up to the next reporting date on August 30, 2023, is advised to understand its profitability and overall stability better.
*says the word "AI" once
* $ONFO +76% at market open pic.twitter.com/gOLBZjlqJ2
— Commonstock (@JoinCommonstock) May 26, 2023
Investment Outlook and Future Prospects
Considering the stock surge and optimistic price forecasts, Onfolio Holdings has promising prospects. Analysts offer a median target price of $3.00 for the company’s stock, signaling an expectation of significant growth within the next 12 months. However, it is essential to note that Onfolio Holdings operates at a loss. Investors should thoroughly evaluate the company’s long-term growth potential and weigh the potential returns against the inherent risks before making investment decisions.
$onfo in news and float are lit pic.twitter.com/Q8eIveRfgd
— …frankyboyz… (@frankyboyz77) May 26, 2023
About MightyDeals.com
Mighty Deals is a free daily deals website aimed at creative professionals focusing on products and services for web designers and developers. The site offers fantastic deals on quality fonts, templates, apps, add-ons, plug-ins, ebooks, icons, and more. The site provides discounts on packages which usually range between 50%-97% off but are only available for a limited time. MightyDeals.com boasts an exceptional return rate from its users and is one of Onfolio Holdings’ highest revenue-generating subsidiaries.
About Onfolio Holdings Inc.
Onfolio acquires and manages a diversified portfolio of online businesses across a broad range of verticals, each with a niche content focus and brand identity. Onfolio acquires firms that meet its investment criteria, being that such businesses operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by our existing team or have strong management teams largely in place. The Company excels at finding acquisition opportunities where the seller has not fully optimized their business. Onfolio’s experience and skillset allow it to add increased value to these existing businesses.
$ONFO #Ai have you seen this stock? Just came out with a competitive AI software that will fight against the tech kings #microsoft #google
— Don’t Look Down (@M_1Ball) May 26, 2023
Conclusion
Onfolio Holdings’ introduction of the generative AI search function for MightyDeals.com has increased the company’s stock price, reflecting the market’s positive response to this innovative technology. The enhanced user experience and the potential for increased revenues have positioned Onfolio Holdings as a leader in the tech industry. However, investors must carefully consider the company’s financial performance and evaluate its long-term growth potential before making investment decisions. Monitoring the company’s performance to the next reporting date will provide valuable insights into its financial health and stability.
$ONFO – "AI program" is laughable. Check it out on https://t.co/0LdCQCWC28. I searched for "shoes" and flower bouquets showed up. I put in a search for "dogs" and african animals came up.
Plus, lockup expiry is tomorrow, so this is a blatant pump and dump: pic.twitter.com/QnYVoDnqqr
— Adam Gefvert, CFA (@Shiningboy) May 26, 2023
We will update you on ONFO when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
Enveric Biosciences, Inc. (NASDAQ: ENVB) shares surged 78% this morning upon approval of some fantastic news. The United States Patent and Trademark Office has granted them a notice of allowance for their patent application concerning a groundbreaking chemical compound called EB-373. This compound is being developed to address the treatment of anxiety disorders.
The forthcoming patent, titled “C4-Carbonothioate-Substituted Tryptamine Derivatives and Methods of Using,” encompasses claims for the composition of matter of a family of revolutionary prodrug derivatives of psilocin. Enveric’s lead product candidate, EB-373, stands out among these derivatives. A Notice of Allowance signifies that the USPTO has determined that a patent should be granted based on the submitted application.
To Discover the Inside Scoop on ENVB, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
$ENVB halted up
— Antonio Costa (@ACInvestorBlog) May 18, 2023
Enveric’s commitment to innovation extends beyond EB-373. They have also submitted additional patent applications to the USPTO, exploring psilocin prodrugs with unique crystalline molecular structures. Moreover, they have taken proactive steps to pursue global coverage of the EVM201 and EVM301 Series through companion Patent Cooperation Treaty and non-US national patent applications. Encouragingly, positive International Search Reports and written opinions have been received under the Patent Cooperation Treaty for most of these applications.
$ENVB 💰💰💰💰💰 pic.twitter.com/qCIxiCpF0E
— FonsieTrader (@FonsieTrader) May 18, 2023
Joseph Tucker, Ph.D., Enveric’s director and CEO, underlined the significance of the USPTO’s favorable decision concerning their lead candidate, EB-373. He highlighted the innovative designs of their psilocin prodrugs within the EVM201 series, differentiating them from conventional counterparts like psilocybin. These novel designs hold the potential to deliver more rapid therapeutic effects, precise control, and reduced gastrointestinal side effects. Tucker emphasized that securing a robust intellectual property portfolio for their new chemical entity prodrugs is pivotal to Enveric’s value proposition and integral to their business strategy of developing cutting-edge small-molecule therapeutics to address mental health disorders.
$ENVB 👇this is an important milestone for the company! The price could increase fivefold wit the time imo.
Enveric Biosciences Receives Notice Of Allowance From US Patent And Trademark Office For Novel Prodrug Of Psilocin
— Swingy John (@daytrader_2020) May 18, 2023
We will update you on ENVB when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
Image by Gino Crescoli from Pixabay
LAVA Therapeutics (NASDAQ: LVTX) Gammabody™ Platform Gains Momentum
Reunion Neuroscience Inc.’s (NASDAQ: REUN) Take-Private Agreement and Its Impact on Mental Health Solutions
Marker Therapeutics, Inc. (NASDAQ: MRKR) Unveils Exciting Pre-Clinical Findings of MT-601 T Cell Therapy in Lymphoma Cells
Aclarion Inc (NASDAQ: ACON): A Breakthrough Partnership
Onfolio Holdings (NASDAQ: ONFO) Unleashing the Power of AI
-
Uncategorized6 months agoMeta Materials Inc (OTCMKTS: MMTLP) Enormous Short Position in Trouble as Next Bridge Hydrocarbons Set to Stop Trading (George Palikaras & John Brda on Corporate Action)
-
Micro Cap Insider2 years agoMedium (KOK PLAY) The Parabolic Rise of Metal Arts (OTCMKTS: MTRT)
-
Media & Technology2 years agoHealthier Choices Management Corp. (OTCMKTS: HCMC) Powerful Comeback Brewing as PMI Patent Infringement Lawsuit Moves Forward
-
Media & Technology3 years ago
AMECA Mining RM; the Rise of Southcorp Capital, Inc. (OTCMKTS: STHC)
-
Media & Technology2 years agoSNPW (Sun Pacific Holding Corp) Power Brewing: 50MW solar farm project in Durango Mexico MOU with Atlas Medrecycler 48,000 SF New Partnership Queensland Australia Solar Farm.
-
BioPharma1 year agoAsia Broadband (OTCMKTS: AABB) On the Move Northbound Since Sub $0.08 Dip as Crypto Innovator Elevates AABB Crypto Exchange & Enters the NFT Space
-
Uncategorized7 months agoMeta Materials Inc (OTCMKTS: MMTLP) Short Squeeze S-1a4 Filing Signals S1 Approval Could Be Days Away (Next Bridge Hydrocarbons Spin-Off)
-
BioPharma2 years agoHumbl Inc (OTCMKTS: HMBL) Major Reversal as Powerful Advisor Rejoins the Team & Looks to Uplist to Major Exchange
